Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A £210,000 donation from the Alan Davidson Foundation (ADF) has been made to the Nuffield Department of Clinical Neurosciences (NDCN) to advance the University’s world leading research into Motor Neurone Disease (MND). The funding will support a project manager for three years to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis and eventually, prevention of all forms of MND.

Alan Davidson with a dog and an inspirational letter he had written
Alan Davidson - ‘Envisioner of Dreams’ who believed that innovation and investment in science is the key to advancing MND treatment

MND symptoms develop insidiously and the early stages can be similar to other conditions, which means that diagnosis can sometimes take a year or more. As a result, damage to the nervous system can go undetected before physical symptoms become apparent. Professor Talbot and his research group work as part of the Oxford Motor Neurone Disease Centre, linking the research to clinical care.

The team has already established promising approaches to treatment in patients who currently have the disease. The aim of this new ground-breaking research is to identify people at risk of MND before symptoms occur, so that treatment can be applied at the early stages when it can be more effective and disability can be prevented.

About 10% of patients with MND have a genetic mutation and each of their close relatives (parents, siblings and children) will have a 50% chance of carrying the gene that leads to MND. The research funded by ADF will sign up 300 – 400 ‘at risk’ individuals, who will be carefully monitored to enable the team to pick up the very earliest signals of the disease. The ultimate aim is to produce a blood test that could be used in general practice to screen for the silent damage occurring in the early phase of MND. A cohort study of this kind, linking in with the established MND network, will be unique, and once the cohort is in place, major research funding will also be sought to analyse the samples donated by people taking part in the study.

Read the full story on the University of Oxford Development Office website. 

Similar stories

Student Prizes for Biomedical Sciences and Medicine 2021-2022

Congratulations to all our Biomedical Sciences students and Medicine students who have been awarded prizes during the 2021-2022 academic year.

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Researchers discover novel form of adaptation in the auditory system

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have found that the auditory system adapts to the changing acoustics of reverberant environments by temporally shifting the inhibitory tuning of cortical neurons to remove reverberation.

20 minutes of daily exercise can keep teens' doctors away

Teenagers should exercise vigorously for at least 20 minutes per day to reap increased cardiorespiratory fitness (CRF), according to a cross-sectional study from the UK led by University of Oxford researchers.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.